Merck Expands GeneGo License to MetaCore to Include All Its Scientists | GenomeWeb
NEW YORK (GenomeWeb News) – GeneGo yesterday said that German pharma Merck has expanded its license to the company’s MetaCore product to allow all Merck employees to access the software “in perpetuity.”
 
Merck researchers will use the technology in both early discovery and new compound safety testing, GeneGo said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.